<DOC>
	<DOCNO>NCT02364180</DOCNO>
	<brief_summary>We intend measure evoke EMG two site subject chronically take pyridostigmine .</brief_summary>
	<brief_title>Electromyography Patients Chronic Pyridostigmine Therapy</brief_title>
	<detailed_description>The investigator intend enroll Patients chronically treated pyridostigmine treatment medical condition present investigator ' outpatient clinic follow appointment . Subjects take pyridostigmine treatment myasthenia gravis exclude . Both adult child older 12 year age approach . Those subject agree participate ask sign inform consent . For participation minor parental ( guardian ) consent subject assent obtain . Those participate answer question pertain medical history undergo electromyograph ( CMAP ) measurement repetitive stimulation 2 site ( ulnar nerve wrist accessory nerve neck ) . Evoked electromyogram record computer hard drive . Eight percent great decrement CMAP response repetitive stimulation consider positive .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<criteria>Subjects take pyridostigmine treatment condition myasthenia gravis Exclusion Criteria Subjects take pyridostigmine treatment myasthenia gravis exclude .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>